Abstract
Promoters are essential on plasmid vectors to initiate transcription of the transgenes when generating therapeutic recombinant proteins expressing mammalian cell lines. High and sustained levels of gene expression are desired during therapeutic protein production while gene expression is useful for cell engineering. As many finely controlled promoters exhibit cell and product specificity, new promoters need to be identified, optimized and carefully evaluated before use. Suitable promoters can be identified using techniques ranging from simple molecular biology methods to modern high-throughput omics screenings. Promoter engineering is often required after identification to either obtain high and sustained expression or to provide a wider range of gene expression. This review discusses some of the available methods to identify and engineer promoters for therapeutic recombinant protein expression in mammalian cells.
Similar content being viewed by others
References
Abeel T, Saeys Y, Bonnet E, Rouzé P, Van De Peer Y (2008) Generic eukaryotic core promoter prediction using structural features of DNA. Genome Res 18:310–323
Addison CL, Hitt M, Kunsken D, Graham FL (1997) Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J Gen Virol 78:1653–1660
Aggarwal S (2012) What’s fueling the biotech engine—2011 to 2012. Nat Biotechnol 30:1191–1197
Barnes LM, Bentley CM, Dickson AJ (2003) Stability of protein production from recombinant mammalian cells. Biotechnol Bioeng 81:631–639
Birch JR, Racher AJ (2006) Antibody production. Adv Drug Deliv Rev 58:671–685
Blazeck J, Alper HS (2013) Promoter engineering: recent advances in controlling transcription at the most fundamental level. Biotechnol J 8:46–58
Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA et al (2010) ChIP-seq identification of weakly conserved heart enhancers. Nat Genet 42:806–810
Boshart M, Weber F, Jahn G (1985) A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521–530
Bulger M, Groudine M (2010) Enhancers: the abundance and function of regulatory sequences beyond promoters. Dev Biol 339:250–257
Chao SH, Harada JN, Hyndman F, Gao X, Nelson CG et al (2004) PDX1, a cellular homeoprotein, binds to and regulates the activity of human cytomegalovirus immediate early promoter. J Biol Chem 279:16111–16120
Chen J, Haverty J, Deng L, Li GH, Qiu P et al (2013) Identification of a novel endogenous regulatory element in Chinese hamster ovary cells by promoter trap. J Biotechnol 167:255–261
Chusainow J, Yang YS, Yeo JH, Toh PC, Asvadi P et al (2009) A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer? Biotechnol Bioeng 102:1182–1196
Clapier CR, Cairns BR (2009) The biology of chromatin remodeling complexes. Annu Rev Biochem 78:273–304
Costa AR, Rodrigues ME, Henriques M, Azeredo J, Oliveira R (2010) Guidelines to cell engineering for monoclonal antibody production. Eur J Pharm Biopharm 74:127–138
Deer JR, Allison DS (2004) High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1α gene. Biotechnol Prog 20:880–889
Dorsch-Hasler K, Keil GM, Weber F (1985) A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci USA 82:8325–8329
Fan L, Kadura I, Krebs LE, Larson J, Bowden D et al (2013) Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter. J Biotechnol 168:652–658
Furey TS (2012) ChIP-seq and beyond: new and improved methodologies to detect and characterize protein–DNA interactions. Nat Rev Genet 13:840–852
Gan Y, Guan J, Zhou S (2012) A comparison study on feature selection of DNA structural properties for promoter prediction. BMC Bioinform 13:4
Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD (2007) FAIRE (formaldehyde-assisted isolation of regulatory elements) isolates active regulatory elements from human chromatin. Genome Res 17:877–885
Grabherr MG, Pontiller J, Mauceli E, Ernst W, Baumann M et al (2011) Exploiting nucleotide composition to engineer promoters. PLoS ONE 6:e20136
Ho SCL, Tong YW, Yang Y (2013) Generation of monoclonal antibody-producing mammalian cell lines. Pharm Bioprocess 1:71–87
Juven-Gershon T, Kadonaga JT (2010) Regulation of gene expression via the core promoter and the basal transcriptional machinery. Dev Biol 339:225–229
Kalwy S (2005) Towards stronger gene expression—a promoter’s tale. In: 19th European Society for Animal Cell Technology (ESACT) meeting, Harrogate, England
Kang M, Kim SY, Lee S, Lee YK, Lee J et al (2005) Human β-globin second intron highly enhances expression of foreign genes from murine cytomegalovirus immediate-early promoter. J Microbiol Biotechnol 15:544–550
Kim DW, Uetsuki T, Kaziro Y, Yamaguchi N, Sugano S (1990) Use of the human elongation factor-1-alpha promoter as a versatile and efficient expression system. Gene 91:217–223
Kim SY, Lee JH, Shin HS, Kang HJ, Kim YS (2002) The human elongation factor 1 alpha (EF-1α) first intron highly enhances expression of foreign genes from the murine cytomegalovirus promoter. J Biotechnol 93:183–187
Kim M, O’Callaghan PM, Droms KA, James DC (2011) A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies. Biotechnol Bioeng 108:2434–2446
Kling J (2012) Fresh from the biotech pipeline 2011. Nat Biotechnol 30:128–131
Kuczewski M, Schirmer E, Lain B, Zarbis-Papastoitsis G (2011) A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line. Biotechnol J 6:56–65
Kwaks TH, Sewalt RG, van Blokland R, Siersma TJ, Kasiem M et al (2005) Targeting of a histone acetyltransferase domain to a promoter enhances protein expression levels in mammalian cells. J Biotechnol 115:35–46
Le Hir H, Nott A, Moore MJ (2003) How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci 28:215–220
Le H, Vishwanathan N, Kantardjieff A, Doo I, Srienc M et al (2013) Dynamic gene expression for metabolic engineering of mammalian cells in culture. Metab Eng 20:212–220
Lee D, Karchin R, Beer MA (2011) Discriminative prediction of mammalian enhancers from DNA sequence. Genome Res 21:2167–2180
LeProust EM, Peck BJ, Spirin K, McCuen HB, Moore B et al (2010) Synthesis of high-quality libraries of long (150mer) oligonucleotides by a novel depurination controlled process. Nucleic Acids Res 38:2522–2540
Lin H, Li QZ (2011) Eukaryotic and prokaryotic promoter prediction using hybrid approach. Theor Biosci 130:91–100
Magnusson T, Haase R, Schleef M, Wagner E, Ogris M (2011) Sustained, high transgene expression in liver with plasmid vectors using optimized promoter–enhancer combinations. J Gen Med 13:382–391
Malik S, Roeder RG (2010) The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 11:761–772
Mariati Ng YK, Chao SH, Yap MG, Yang Y (2010) Evaluating regulatory elements of human cytomegalovirus major immediate early gene for enhancing transgene expression levels in CHO K1 and HEK293 cells. J Biotechnol 147:160–163
Melnikov A, Murugan A, Zhang X, Tesileanu T, Wang L et al (2012) Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat Biotechnol 30:271–277
Nelson JA, Reynolds-Kohler C, Smith BA (1987) Negative and positive regulation by a short segment in the 5′-flanking region of the human cytomegalovirus major immediate-early gene. Mol Cell Biol 7:4125–4129
Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–200
Nott A, Meislin SH, Moore MJ (2003) A quantitative analysis of intron effects on mammalian gene expression. RNA 9:607–617
Ogawa R, Kagiya G, Kodaki T, Fukuda S, Yamamoto K (2007) Construction of strong mammalian promoters by random cis-acting element elongation. Biotechniques 42:628–633
Ong CT, Corces VG (2011) Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet 12:283–293
Osterlehner A, Simmeth S, Göpfert U (2011) Promoter methylation and transgene copy numbers predict unstable protein production in recombinant chinese hamster ovary cell lines. Biotechnol Bioeng 108:2670–2681
Patwardhan RP, Hiatt JB, Witten DM, Kim MJ, Smith RP et al (2012) Massively parallel functional dissection of mammalian enhancers in vivo. Nat Biotechnol 30:265–270
Pedersen AG, Baldi P, Chauvin Y, Brunak S (1999) The biology of eukaryotic promoter prediction—a review. Comput Chem 23:191–207
Pham P, Kamen A, Durocher Y (2006) Large-scale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol 34:225–237
Pontiller J, Gross S, Thaisuchat H, Hesse F, Ernst W (2008) Identification of CHO endogenous promoter elements based on a genomic library approach. Mol Biotechnol 39:135–139
Pontiller J, Maccani A, Baumann M, Klancnik I, Ernst W (2010) Identification of CHO endogenous gene regulatory elements. Mol Biotechnol 45:235–240
Prentice HL, Tonkin CJD, Caamano L, Sisk WP (2007) High level expression of proteins using sequences from the ferritin heavy chain gene locus. J Biotechnol 128:50–60
Quilici LS, Silva-Pereira I, Andrade AC, Albuquerque FC, Brigido MM et al (2013) A minimal cytomegalovirus intron A variant can improve transgene expression in different mammalian cell lines. Biotechnol Lett 35:21–27
Reik A, Zhou Y, Collingwood TN, Warfe L, Bartsevich V et al (2007) Enhanced protein production by engineered zinc finger proteins. Biotechnol Bioeng 97:1180–1189
Schlabach MR, Hu JK, Li M, Elledge SJ (2010) Synthetic design of strong promoters. Proc Natl Acad Sci USA 107:2538–2543
Smale ST, Kadonaga JT (2003) The RNA polymerase II core promoter. Annu Rev Biochem 72:449–479
Song L, Zhang Z, Grasfeder LL, Boyle AP, Giresi PG et al (2011) Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res 21:1757–1767
Sumitomo Y, Higashitsuji H, Liu Y, Fujita T, Sakurai T et al (2012) Identification of a novel enhancer that binds Sp1 and contributes to induction of cold-inducible RNA-binding protein (cirp) expression in mammalian cells. BMC Biotechnol 12(1):72
Swindle CS, Kim HG, Klug CA (2004) Mutation of CpGs in the murine stem cell virus retroviral vector long terminal repeat represses silencing in embryonic stem cells. J Biol Chem 279:34–41
Thaisuchat H, Baumann M, Pontiller J, Hesse F, Ernst W (2011) Identification of a novel temperature sensitive promoter in CHO cells. BMC Biotechnol 11(1):51
Thomsen DR, Stenberg RM, Goins WF, Stinski MF (1984) Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci USA 81:659–663
Uetsuki T, Naito A, Nagata S, Kaziro Y (1989) Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha. J Biol Chem 264:5791–5798
Weber F, de Villiers J, Schaffner W (1984) An SV40 “enhancer trap” incorporates exogenous enhancers or generates enhancers from its own sequences. Cell 36:983–992
Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393–1398
Xia W, Bringmann P, McClary J, Jones PP, Manzana W et al (2006) High levels of protein expression using different mammalian CMV promoters in several cell lines. Protein Expr Purif 45:115–124
Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z et al (2011) The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 29:735–741
Yang Y, Mariati Chusainow J, Yap MG (2010) DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines. J Biotechnol 147:180–185
Acknowledgment
This work was supported by the Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ho, S.C.L., Yang, Y. Identifying and engineering promoters for high level and sustainable therapeutic recombinant protein production in cultured mammalian cells. Biotechnol Lett 36, 1569–1579 (2014). https://doi.org/10.1007/s10529-014-1523-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-014-1523-4